ARTICLE | Company News
Amrad Development Pty Ltd., Collateral, Ludwig Institute for Cancer Research deal
September 8, 1998 7:00 AM UTC
CLTX terminated its 1997 licensing agreement with the other parties for the use of the VEGF-B gene ( vascular endothelial growth factor B) in therapies for myocardial ischemia (see BioCentury, April ...